Skip to main content Skip to section navigation Skip to footer

Mydecine Innovations Group Inc.

  • Home
  • About
    • Overview
    • Company History
    • Acquisitions
    • Partnerships
    • Leadership Team
    • Board of Directors
    • Research & Development Team
    • Medical, Scientific and Technology Advisory Board
  • Our Approach
    • IP & Drug Development
    • Clinical Trials
    • Technology
  • Drug Supply
    • Investigational Drug Supply
    • Special Access Program
  • News & Media
    • Blog
    • Press Releases
    • In The News
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Results
    • Stock Data
    • SEDAR
    • Governance
    • FAQs
  • Contact
  • Careers
  • Search

Press Releases

News & Media

News & Media

  • Blog
  • Press Releases
  • In The News
Apr 07, 2021 7:30am EDT

Mydecine Announces API-naming structure of Four Lead Candidates and Prepares for Pre-IND

Mar 23, 2021 7:30am EDT

Mydecine Innovations Group Announces Migration to NEO Exchange

Mar 16, 2021 7:30am EDT

Mydecine Innovations Group Provides Update on European Operations

Mar 01, 2021 7:30am EST

Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain

Feb 17, 2021 7:00am EST

Mydecine Innovations Group Announces Filing of a Provisional Patent for Mindleap’s Mental Health Technology

Feb 03, 2021 7:30am EST

Mydecine Innovations Group Appoints Josephine Wu to Board of Directors

Feb 01, 2021 7:30am EST

Mydecine Innovations Group Receives Conditional Approval to List on NEO Exchange

Jan 28, 2021 7:30am EST

Mydecine Innovations Group Sponsors Study on Neuron Level Response to Psilocybin at University of Maryland

Jan 27, 2021 7:30am EST

Mydecine Innovations Group Files Application to list to the NASDAQ

Jan 22, 2021 7:30am EST

Mydecine Innovations Group Included in First-Ever Psychedelics ETF

rss_feed News RSS
  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • arrow_forward

Sign up for our Newsletter!

twitter Linkedin Instagram
©2022 Mydecine Innovations Group Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap